son-1210
Generic: IL12-FHAB-IL15·Code: SON-1210
son-1210: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG) | Phase 1/Phase 2 |
Get deeper analysis on son-1210
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis